Regli Adrian, Sommerfield Aine, von Ungern-Sternberg Britta S
Intensive Care Unit, Fiona Stanley Hospital, Perth, Western Australia, Australia.
School of Human Sciences, The University of Western Australia, Perth, Western Australia, Australia.
Paediatr Anaesth. 2022 Feb;32(2):148-155. doi: 10.1111/pan.14373. Epub 2021 Dec 13.
Due to the high prevalence of asthma and general airway reactivity, anesthesiologists frequently encounter children with asthma or asthma-like symptoms. This review focuses on the epidemiology, the underlying pathophysiology, and perioperative management of children with airway reactivity, including controlled and uncontrolled asthma. It spans from preoperative optimization to optimized intraoperative management, airway management, and ventilation strategies. There are three leading causes for bronchospasm (1) mechanical (eg, airway manipulation), (2) non-immunological anaphylaxis (anaphylactoid reaction), and (3) immunological anaphylaxis. Children with increased airway reactivity may benefit from a premedication with beta-2 agonists, non-invasive airway management, and deep removal of airway devices. While desflurane should be avoided in pediatric anesthesia due to an increased risk of bronchospasm, other volatile agents are potent bronchodilators. Propofol is superior in blunting airway reflexes and, therefore, well suited for anesthesia induction in children with increased airway reactivity.
由于哮喘的高患病率和普遍的气道反应性,麻醉医生经常会遇到患有哮喘或哮喘样症状的儿童。本综述重点关注气道反应性儿童的流行病学、潜在病理生理学以及围手术期管理,包括控制良好和控制不佳的哮喘。内容涵盖从术前优化到优化的术中管理、气道管理和通气策略。支气管痉挛有三个主要原因:(1)机械性(如气道操作),(2)非免疫性过敏反应(类过敏反应),以及(3)免疫性过敏反应。气道反应性增加的儿童可能受益于使用β-2激动剂进行术前用药、无创气道管理以及气道装置的深度移除。虽然由于支气管痉挛风险增加,小儿麻醉中应避免使用地氟烷,但其他挥发性麻醉药是强效支气管扩张剂。丙泊酚在抑制气道反射方面更具优势,因此非常适合气道反应性增加的儿童进行麻醉诱导。